Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|April 25, 2022
Natural Killer Cells in Multiple Sclerosis: Entering the StageJarne Beliën, An Goris, Patrick MatthysMolecular Neurobiology|May 13, 2026
Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink ProteomicsEline Bernaerts, Marie Rutten, Amber De Visscher, et al.Nature Communications|June 12, 2024
CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosisJarne Beliën, Stijn Swinnen, Robbe D'hondt, et al.The Journal of Clinical Investigation|January 2, 2026
Human adenosine deaminase type 2 deficiency enhances NK cell activation but impairs maturation and functionJarne Beliën, Amber De Visscher, Bethany Pillay, et al.JHEP Reports : Innovation in Hepatology|January 21, 2026
STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammationAmber De Visscher, Jarne Beliën, Eline Bernaerts, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.Pageof 1